baber/WOPTO huggingface dataset:
Patent AU-2018365007-A1 (AU)
Title: Method for manufacturing a closure for a product-retaining container
Inventor: THOMETSCHEK MARC ANTON CHARLES
IPC: B65D39/00
Filed: 2018-11-09
Abstract: A method for manufacturing a closure constructed for being inserted and securely retained in a portal-forming neck of a product-retaining container is provided. Such method may include intimately combining a plurality of particles comprising cork and having a specified particle size distribution with a plastic material including one or more thermoplastic polymers, optionally in combination with other constituent(s) to form a composition, heating the composition to form a melt, extruding or molding a closure precursor from the melt to provide a specified water content range, and optionally cutting and/or finishing the closure precursor. A composition for use in manufacturing a closure for a product-retaining container includes a plurality of particles comprising cork and having a specified particle size distribution with a plastic material including at least one thermoplastic polymer, optionally with other constituent(s). A closure produced from the composition and use of a closure are also provided.
Patent AU-2018374389-A1 (AU)
Title: Nucleic acid-binding photoprobes and uses thereof
Inventor: KUMARAVEL GNANASAMBANDAM
IPC: A61K51/10
Filed: 2018-11-30
Abstract: The present invention relates to photoactivatable compounds and methods of use thereof for determining binding site and other structural information about RNA transcripts. The invention also provides methods of identifying RNA transcripts that bind compounds and are thus druggable, methods of screening drug candidates, and methods of determining drug binding sites and/or accessible or reactive sites on a target RNA.
Patent AU-2018378980-A1 (AU)
Title: A sample holder for imaging a plurality of samples
Inventor: FALK HENNING
IPC: G01N21/64
Filed: 2018-11-29
Abstract: A sample holder comprises one or more elongated sample tubes. The one or more elongated sample tubes are adapted for accommodating a plurality of samples to be imaged at an imaging position. The imaging position is defined by at least one illumination objective lens and at least one detection objective lens of a microscope. A microscope is disclosed, comprising at least one illumination objective lens and at least one detection objective lens, which define an imaging position. The microscope further comprises a sample holder for holding a plurality of samples. The sample holder is moveable with respect to the imaging position.A method for imaging a plurality of samples by means of the microscope is disclosed.
Patent AU-2018379418-A1 (AU)
Title: Knee orthosis with helicoidal axis and method of design and fabrication thereof
Inventor: BLEAU JACINTE
IPC: A61F5/01
Filed: 2018-12-04
Abstract: A knee orthosis is provided. In described embodiments, the knee orthosis is designed to follow a natural movement of a wearer's knee along an asymmetric helicoidal axis of rotation. In some embodiments, the knee orthosis has hinges with shells having displacing geometric centers which do not coincide. In some embodiment, the knee orthosis is made of femoral and tibial hinges manufactured as single integral pieces. In some embodiments, the orthosis is configured to realign the wearer's knee in a frontal plane. Corresponding methods for designing and manufacturing a custom knee orthosis are also provided.
Patent AU-2018380132-A1 (AU)
Title: Tubulin inhibitors
Inventor: LIN TOM
IPC: A61K31/404
Filed: 2018-12-05
Abstract: Provided herein are compounds, pharmaceutical compositions, and methods of treatment for various diseases, such as cancer. In one aspect, the method comprises the treatment of brain cancers or metastatic cancers that spread to the brain.
Patent AU-2018411164-A1 (AU)
Title: Air-conditioning apparatus
Inventor: KURIHARA MAKOTO
IPC: F24F11/52
Filed: 2018-03-01
Abstract: This air conditioner includes: an air temperature detecting means for detecting the air temperature of a space to be air-conditioned; a human body sensing means for sensing a human body in the space to be air-conditioned; an estimating means for estimating the hot/cold sensations of a person sensed by the human body sensing means; and a control means for correcting the value of the air temperature or a set temperature on the basis of the hot/cold sensations estimated by the estimating means for all people who have been sensed and using the corrected value to control a refrigeration cycle.
Patent AU-2019201384-A1 (AU)
Title: Moving robot and moving robot system
Inventor: LEE JAEHOON
IPC: G05D1/02
Filed: 2019-02-27
Abstract: Disclosed is a moving robot and a moving robot system, the moving robot which includes: a boundary signal detector configured to detect a proximity boundary signal D generated in a proximity boundary area in which a portion of a first travel area and a portion of a second travel area are proximal to each other; and a controller configured to define a proximity boundary line based on the proximity boundary signal, and control the travelling ] unit such that the body performs a homing travel which indicates travelling along the proximity boundary line. I L.I I'-t Fig. 12 BOUNDARY SIGNAL N TRAVEL IN ACCORDANCE WITH BOUNDARY SIGNAL S20 BOUNDARY NO WITH POXIMIY BONDARY ~S40 Is OCKING POSITIO NO SIGNAL DETETD DOCKING TRAVEL ~S60
Patent AU-2019201907-A1 (AU)
Title: Planar zone in prosthetic heart valve leaflet
Inventor: BRUCHMAN WILLIAM C
IPC: A61F2/24
Filed: 2019-03-19
Abstract: Described embodiments are directed toward prosthetic valves having leaflets of a particular shape that improves bending character without requiring a long length valve. In accordance with an embodiment, a prosthetic valve comprises a leaflet frame, a plurality of leaflets coupled to the leaflet frame, each leaflet having a planar zone in a central region when the valve is in the closed position and not under fluid pressure, the planar zone having a shape either (1) of a truncated wedge of a circle that is not in contact with the leaflet frame or (2) an isosceles trapezoid that is not in contact with the leaflet frame. 11187712_1 (GHMattes) P100032.AU.2 WO 2014/099282 PCT/US2013/071632
Patent AU-2019202000-A1 (AU)
Title: Methods and compositions for treating disorders
Inventor: NG HOWARD
IPC: A61K31/522
Filed: 2019-03-22
Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.
Patent AU-2019203598-A1 (AU)
Title: Method and compositions for treating inflammatory pain using inhibitors of the p75 neurotrophin receptor
Inventor: Zhou xin-fu
IPC: A61K39/395
Filed: 2019-05-22
Abstract: The present disclosure relates to the field of a new class of medicine for the treatment of pain.  
The disclosure, at least in part, to methods and compositions for treating inflammatory pain using 
inhibitors of the p75 neurotrophin receptor. This disclosure provides examples for treating 
inflammatory pain in arthritis, general inflammation and autoimmune diseases.
Patent AU-2019213432-A1 (AU)
Title: A tie down apparatus and system
Inventor: REARDON ANTHONY
IPC: B60P7/08
Filed: 2019-08-09
Abstract: A tie down system having a first attachment member having an 
engagement portion adapted to engage with a portion of a track, a second 
5 attachment member having an engagement portion adapted to engage with a portion 
of the track, the second attachment member rotatably attached relative to the first 
attachment member, a cam member rotatably attached relative to the first 
attachment member, and rotatable between a biased position in which the cam 
member engages with a portion of the track and a release position in which the cam 
10 member is disengaged from the track, and a connection portion adapted to connect 
to a strap, wherein the first and second attachment members are rotatable relative to 
each other between an engagement position in which the engagement portions 
engage with the track and inhibit movement of the attachment members relative to 
the track, and an open position in which the attachment members are movable 
15 relative to the track.
1/2 
10 
42 28 
24 
418 
16 
Figure 1
Patent AU-2019219718-A1 (AU)
Title: Carbonated Beverage, Syrup Used For Preparing Carbonated Beverage, Method For Manufacturing Carbonated Beverage, And Method For Suppressing Foaming In Carbonated Beverage
Inventor: URAI SOICHIRO
IPC: A23L2/60
Filed: 2019-08-19
Abstract: An embodiment of the present invention provides a carbonated beverage comprising a stevia extract in which foaming is suppressed and a method for producing the same. A carbonated beverage comprising RebA and RebD and/or RebM, wherein a content of RebA is 500 ppm or less; a content of RebD and/or RebM is 486 ppm or less; ((RebD and/or RebM)/RebA) is 0.45 or more in a mass ratio; and a total content of RebA and RebD and/or RebM is 0.5 to 13.5 in Brix in terms of sucrose.
Patent AU-2019228474-A1 (AU)
Title: PD-1 agonist antibodies and uses thereof
Inventor: CHAI QING
IPC: A61K39/00
Filed: 2019-02-22
Abstract: The present invention relates to anti-human PD-1 agonist antibodies, and uses thereof for treating autoimmune disorders such as rheumatoid arthritis or for decreasing rejection of transplanted cells and/or tissues.
Patent AU-2019232878-A1 (AU)
Title: System and methods for enhanced approval of a payment transaction
Inventor: WIESMAN MARK B
IPC: G06Q20/40
Filed: 2019-09-19
Abstract: P01831-US-PCT SYSTEM AND METHODS FOR ENHANCED APPROVAL OF A PAYMENT TRANSACTION A computer-implemented method for determining a level of confidence that a payment transaction is not fraudulent is provided. The method is implemented using an assurance exchange (AE) computer device in communication with a memory. The method includes receiving authentication data associated with a candidate payment 5 transaction being conducted by a cardholder via a website associated with a merchant from the merchant, storing the authentication data, receiving an authorization request message for the candidate payment transaction from a payment processor, retrieving the authentication data for the candidate payment transaction based on the authorization request message, and calculating an assurance level score based on the authentication 10 data and the authorization request message. The assurance level score represents a level of confidence that the candidate payment transaction is not fraudulent. The method also includes transmitting the authorization request message including the assurance level score to an issuer processor.
Patent AU-2019264935-A1 (AU)
Title: Edible pet chew for dental care of companion animals
Inventor: ALBERT KAREN LORI
IPC: A01K15/02
Filed: 2019-05-10
Abstract: Edible pet chews are made of one or two layers, each layer comprising a thin slice of sweet potato, and one of the layers being processed to form irregularities, the layers being rolled into a tubular body and treated with heat to form a single- or dual-layered dehydrated tube having the irregularities oriented toward the interior cavity of the tubular body, the interior cavity being fillable with a beneficial material of suitable viscosity to provide a beneficial or therapeutic effect to the animal as the animal chews on the edible pet chew.
Patent AU-2019277675-A1 (AU)
Title: Sporicidal methods and compositions
Inventor: AN WEIDONG
IPC: A01N37/00
Filed: 2019-05-31
Abstract: Provided herein are methods and compositions for the reduction of endospore contamination of a substrate with percarboxylic acid-based compositions. The methods can include the step of continuously monitoring the oxidation-reduction potential of the percarboxylic acid-based compositions.
Patent AU-2019291882-A1 (AU)
Title: Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies
Inventor: NOVINA CARL
IPC: C07D401/14
Filed: 2019-06-27
Abstract: Disclosed are compositions and methods for treating cancers characterized by the presence of solid tumors, which simultaneously target a plurality of targets on cancer cells using single CAR T construct.
Patent AU-2019293044-A1 (AU)
Title: Compositions and methods for the treatment of anesthesia-induced neurotoxicity
Inventor: MANSELL JOHN
IPC: C12N15/113
Filed: 2019-06-28
Abstract: A formulation comprising an oligonucleotide selected from the group consisting of an oligonucleotide having one of SEQ ID No.:1 through SEQ ID No.:42 or a variant thereof. Also, a method of treating anesthesia-induced neurotoxicity. The method may comprise administering the formulation. The formulation may be administered prior to, concomitant with, subsequent to, or combinations thereof administration of a general anesthetic comprising a fluorinated compound. The oligonucleotide may be incorporated into a carrier system, for example, a liposome, a biodegradable polymer, a hydrogel, or a cyclodextrin, a nucleic acid complex, a virosome, or combinations thereof. Also, a method of treating anesthesia-induced neurotoxicity.
Patent AU-2019307437-A1 (AU)
Title: Method for monitoring PDCCH, and terminal and network device
Inventor: JI ZICHAO
IPC: H04W28/18
Filed: 2019-07-16
Abstract: Provided are a method for monitoring a PDCCH, and a terminal and a network device, which relate to the technical field of communications and are used for solving the problem in the related art that since the maximum processing capacity of a UE for performing blind detection on a CC or a PDCCH of a cell during cross-carrier scheduling is not limited, a corresponding blind detection behavior cannot be rationally configured for the UE. The method comprises: monitoring a PDCCH according to PDCCH blind detection capacity information of N scheduling cells, wherein the N scheduling cells are cells from among M cells configured for a terminal by a network device, and the M cells further comprise: X scheduled cells; the PDCCH blind detection capacity information of the N scheduling cells is relevant to cell parameters of the M cells; the PDCCH blind detection capacity information of the N scheduling cells is used for indicating the maximum processing capacity of the terminal for performing blind detection on the PDCCH under each scheduling cell or the N scheduling cells within a unit time; and M and N are positive integers greater than or equal to 1, X is a positive integer greater than or equal to 0, and M is equal to N + X.
Patent AU-2019324158-A1 (AU)
Title: Auto-adjustable buoyancy pressure vessel for scuba
Inventor: CAHANA AVIAD
IPC: B63C11/00
Filed: 2019-08-21
Abstract: SCUBA diving equipment is composed of a heavy SCUBA pressure vessel, buoyancy compensation device and a heavy weight system. Together with a constricting exposure suit the current setup makes for a rather cumbersome system. Perfect buoyancy is a term used in SCUBA diving to describe the ability of the diver to maintain its vertical position in the water column. Doing so requires a thorough understanding of the governing physics principles as well as considerable practice time. Together, the cumbersome nature of standard SCUBA systems and the physical and mental requirements of operating said systems underwater are a commercial hurdle, preventing many individuals from entering the sport. The present invention provides systems that can significantly simplify both elements by allowing water to occupy some of the pressure vessel internal volume. Such a pressure vessel can be used as both the breathing gas source as well as a buoyancy control device, reducing or even eliminating the need for additional weights and a separate buoyancy compensation device. Embodiments of the present invention also comprise a control system and one or more sensors to provide an automatic buoyancy system.
Patent AU-2019347730-A1 (AU)
Title: Method of providing safe administration of an anti-CD154 antibody
Inventor: RIGBY MARK
IPC: C07K16/18
Filed: 2019-09-24
Abstract: Methods for clinically proven safe administration of an anti-CD 154 antibody or antigen binding fragment thereof by subcutaneous or intravenous administration are provided. Also provided are methods for clinically proven safe treatment of an autoimmune disease by subcutaneous or intravenous administration of an anti-CD 154 antibody or antigen binding fragment thereof, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and Sjögren' s Syndrome.
Patent AU-2019358519-A1 (AU)
Title: Selection by means of artificial transactivators
Inventor: GENOVESE PIETRO
IPC: A61K38/46
Filed: 2019-10-11
Abstract: A method for selecting genome edited cells and/or for enrichment of genome edited cells in a population of cells comprising: (a) introducing into a cell or a population of cells at least one first component, at least one second component and at least one third component; and (b) selecting the genome edited cells which transiently express or transiently upregulate a nucleotide sequence encoding a selector.
Patent AU-2019359083-A1 (AU)
Title: Aluminum-zinc-magnesium-copper alloy containing ceramic particles, preparation method therefor and use thereof
Inventor: WANG HAOWEI
IPC: C22C21/10
Filed: 2019-07-12
Abstract: Disclosed are an aluminum-zinc-magnesium-copper alloy containing ceramic particles, a preparation method therefor and the use thereof. The aluminum-zinc-magnesium-copper alloy containing ceramic particles comprises the following components in weight percentage: 4.9%-8.5% of Zn, 1.8%-3.0% of Mg, 1.0%-2.7% of Cu, 0.02%-0.3% of Zr, 0.03%-0.3% of Cr, 0.01%-0.4% of Fe, 0.01%-0.3% of Si, 0.01%-0.4% of Mn, less than 20% of TiB
Patent AU-2019384115-A1 (AU)
Title: Suicide gene
Inventor: REZVANI KATY
IPC: A61K38/19
Filed: 2019-11-18
Abstract: Embodiments of the disclosure encompass particular TNF-alpha mutants that are nonsecretable and membrane bound, thereby providing a target for inhibition in cells that express the mutants. In specific embodiments, the TNF-alpha mutants are utilized as a suicide gene in cells employed for adoptive cell therapy for an individual, wherein at a desired time the individual is provided one or more anti-TNF-alpha antibodies that bind the membrane bound TNF-alpha and elicit complement-dependent cytotoxicity for the cells. The TNF-alpha mutant can also be used as a way of tracking the transduced cells
Patent AU-2019418785-A1 (AU)
Title: Portable dishwasher
Inventor: CALLAHAN JEREMIAH M
IPC: A47L15/00
Filed: 2019-12-30
Abstract: A dishwasher has a housing (10) with a wash chamber (20) and a top wall (204) with a non-planar surface (214; 214") facing downwardly into the wash chamber, the surface having portions (216, 218; 226, 228) facing downwardly and facing in different horizontal directions (H1, H2; HX, HY, HP, HQ). Nozzles (402) mounted within the wash chamber spray a liquid upwardly within the wash chamber. The surface portions redistribute the upwardly-sprayed water in horizontal directions to provide a more uniform washing action. A portable dishwasher may have a fresh water reservoir (422) and a used water reservoir (430) mounted in the housing beneath the wash chamber. The used water reservoir may be removably mounted in the housing so that the user can remove used wash water by removing the used water reservoir. The portable dishwasher can be used at a location remote from a sink.
Patent AU-2019445053-A1 (AU)
Title: Shaping liquid material in a cryostorage bag to obtain desired solid shape
Inventor: SCHYVER BRIAN
IPC: B65D1/02
Filed: 2019-10-02
Abstract: Systems, devices and methods for shaping a liquid material within a cryostorage bag while undergoing a freezing procedure.
Patent AU-2020201081-A1 (AU)
Title: Detection of genetic or molecular aberrations associated with cancer
Inventor: LO YUK MING DENNIS
IPC: G16B20/10
Filed: 2020-02-14
Abstract: Systems, apparatus, and methods are provided for determining genetic or molecular aberrations in a biological sample from an organism. Biological samples including cell-free DNA fragments are analyzed to identify imbalances in chromosomal regions, e.g., due to deletions and/or amplifications in a tumor. Multiple loci are used for each chromosomal region. Such imbalances can then be used to diagnose (screen) a patient for cancer, as well as prognosticate a patient with cancer, or to detect the presence or to monitor the progress of a premalignant condition in a patient. The severity of an imbalance as well as the number of regions exhibiting an imbalance can be used. A systematic analysis of non-overlapping segments of a genome can provide a general screening tool for a sample. Additionally, a patient can be tested over time to track severity of each of one or more chromosomal regions and a number of chromosomal regions to enable screening and prognosticating, as well as monitoring of progress (e.g. after treatment) 12050975_1 (GHMatters) P88951.AU.3 Determine first and second haplotypes of chromosomal region 1020 Identify location in reference genome and allele of nucleic acid molecules form sample 1030 Identify a first group of nucleic acid molecules as being from the first haplotype based on the identified locations and alleles 1040 Identify a second group of nucleic acid molecules as being from the second haplotype based on the identified locations and alleles 1050 Calculate a first value of the first group Calculate a second value of the second group 1070 Compare the first value to the second value to determine a classification of whether the chromosomal region exhibits a deletion or an amplification.
Patent AU-2020203102-A1 (AU)
Title: Surgical cutting instrument
Inventor: NGUYEN THOAI
IPC: A61B17/32
Filed: 2020-05-12
Abstract: A surgical cutting instrument including a first tubular member, a second tubular member, a sleeve member, a third tubular member, and an orientation member. A distal section of the first tubular member includes a cutting tip. The distal region of the second tubular member forms a cutting window. The first elongated member is co-axially disposed within the second tubular member such that the cutting tip is selectively exposed at the cutting window. The first and second tubular members are co-axially disposed within the sleeve member. The third tubular member is co-axially disposed around the intermediate section of the first tubular member, the intermediate region of the second tubular member and the sleeve member. The orientation member is rotatable to transmit a rotational force applied to the orientation member to selectively rotate the second and third tubular members relative to the sleeve to effectuate spatial rotation of the cutting window.
Patent AU-2020206415-A1 (AU)
Title: Peptides and compositions for use in cosmetics
Inventor: GRAU-CAMPISTANY ARIADNA
IPC: A61K8/64
Filed: 2020-01-03
Abstract: The present invention relates to a family of peptides which prevent and/or reduce the signs of skin aging (including chronological and/or environmental aging) and which are useful for skin firming; cosmetic compositions comprising said peptides and cosmetic uses and methods of said peptides or cosmetic compositions.
Patent AU-2020211019-A1 (AU)
Title: Device for an extracorporeal blood treatment
Inventor: SPICKERMANN REINER
IPC: A61M1/16
Filed: 2020-01-24
Abstract: The invention relates to a device for an extracorporeal blood treatment, comprising an extracorporeal blood circuit in which a dialyzer is arranged and comprising a dialysate circuit. The blood circuit is fluidically connected to a first chamber, and the dialysate circuit is fluidically connected to a second chamber of the dialyzer. The two chambers are separated by a semipermeable membrane, and a dialysate pump is provided in the dialysate circuit in order to pump the dialysis solution. The device has a control unit which is designed to operate the device in a first phase and a second phase which follows the first phase, and the dialysate pump is operated with a lower flow rate in the first phase than in the second phase and/or the dialysate pump pumps a dialysis solution with a higher concentration, with respect to at least one component, in the first phase than in the second phase.